SciVision Biotech Inc Working Capital to Net Assets Ratio
SciVision Biotech Inc working capital to net assets ratio. SciVision Biotech Inc (1786) has a Working Capital to Net Assets ratio of 62.0% as of March 2026. Working capital of NT$1.15 Billion (current assets of NT$1.53 Billion minus current liabilities of NT$373.20 Million) is measured against net assets of NT$1.86 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 1786 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SciVision Biotech Inc (2009–2025)
Working capital to net assets ratio of SciVision Biotech Inc from 2009 to 2025. This chart shows how SciVision Biotech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the ratio stands at 62.0%, reflecting working capital of NT$1.15 Billion against net assets of NT$1.86 Billion TWD. See 1786 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
SciVision Biotech Inc Working Capital to Net Assets Ratio by Year (2009–2025)
SciVision Biotech Inc working capital to net assets ratio by year from 2009 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SciVision Biotech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SciVision Biotech Inc (1786) total assets.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 63.3% | NT$1.25 Billion | NT$1.98 Billion | NT$1.43 Billion | NT$174.65 Million | ▲ +19.5 pp |
| 2024 | 43.7% | NT$829.35 Million | NT$1.90 Billion | NT$1.17 Billion | NT$337.07 Million | ▼ -9.1 pp |
| 2023 | 52.8% | NT$858.92 Million | NT$1.63 Billion | NT$1.00 Billion | NT$144.99 Million | ▲ +3.0 pp |
| 2022 | 49.8% | NT$752.95 Million | NT$1.51 Billion | NT$881.03 Million | NT$128.08 Million | ▲ +15.4 pp |
| 2021 | 34.5% | NT$499.60 Million | NT$1.45 Billion | NT$925.24 Million | NT$425.64 Million | ▲ +3.7 pp |
| 2020 | 30.8% | NT$431.84 Million | NT$1.40 Billion | NT$553.45 Million | NT$121.61 Million | ▲ +1.6 pp |
| 2019 | 29.1% | NT$396.55 Million | NT$1.36 Billion | NT$546.78 Million | NT$150.22 Million | ▲ +0.1 pp |
| 2018 | 29.0% | NT$312.83 Million | NT$1.08 Billion | NT$523.55 Million | NT$210.72 Million | ▼ 0.0 pp |
| 2017 | 29.0% | NT$265.57 Million | NT$914.45 Million | NT$449.66 Million | NT$184.09 Million | ▼ -15.5 pp |
| 2016 | 44.6% | NT$398.65 Million | NT$894.21 Million | NT$586.54 Million | NT$187.88 Million | ▼ -7.9 pp |
| 2015 | 52.5% | NT$497.96 Million | NT$948.60 Million | NT$565.62 Million | NT$67.67 Million | ▼ -22.6 pp |
| 2014 | 75.1% | NT$767.88 Million | NT$1.02 Billion | NT$810.61 Million | NT$42.73 Million | ▼ -11.5 pp |
| 2013 | 86.6% | NT$938.15 Million | NT$1.08 Billion | NT$963.40 Million | NT$25.25 Million | ▲ +12.5 pp |
| 2012 | 74.1% | NT$315.56 Million | NT$425.98 Million | NT$344.04 Million | NT$28.48 Million | ▲ +4.0 pp |
| 2011 | 70.0% | NT$254.71 Million | NT$363.70 Million | NT$267.64 Million | NT$12.94 Million | ▲ +74.1 pp |
| 2010 | -4.0% | NT$-4.52 Million | NT$111.73 Million | NT$68.22 Million | NT$72.74 Million | ▲ +46.2 pp |
| 2009 | -50.3% | NT$-42.26 Million | NT$84.09 Million | NT$24.49 Million | NT$66.75 Million | — |